Qingdao Kingway Pharmtech Co., Ltd. is a direct producer, focusing on developing advanced technologies for organic synthesis. We are actively engaged in R&D and production of Active Pharmaceuticals Ingredient\'s (APIs) and intermediate, fine chemicals. Also we can provide service of customs synthesis, contract manufacturing and toll manufacturing. Main products include Dorzolamide, Brinzolamide, Olopatadine HCL, Macitentan, Silodosin, Pimobendan, Teneligliptin, Apixaban and its intermediates.
more >
Year of Establishment:
2012
Total Assets(USD):
5,000,000 To 5,999,999
Total Number of Staff:
50 to 59
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
5,000,000 To 5,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: